书目名称 | Drug Adherence in Hypertension and Cardiovascular Protection |
编辑 | Michel Burnier |
视频video | |
概述 | Illustrates how to apply new technologies in assessing and monitoring drug adherence..Sheds light on the importance of adherence monitoring in clinical trials..Highlights the role of a multidisciplina |
丛书名称 | Updates in Hypertension and Cardiovascular Protection |
图书封面 |  |
描述 | .This book provides a critical and comprehensive review of the methodologies available for measuring drug adherence in clinical practice, including those relying on emerging technologies. The authors discuss the risk factors of non-adherence and shed light on how to identify patients at risk of poor adherence. Drug therapies in chronic diseases rely heavily on the patient‘s adherence, since drugs that are not taken are ineffective and leave the patient at high risk of developing clinical complications. Given the absence of new drugs for the treatment of hypertension, drug adherence is particularly important in these patients to improve blood pressure control. The book further investigates a new aspect, namely the importance of drug adherence in clinical trials and studies and draws attention to the limits of developing drugs without significant information on drug adherence. Several chapters are dedicated to the importance of adherence in specific forms of hypertension, such as resistant hypertension, dyslipidemia and hypertension associated with cardiovascular risk. As experts confronted with drug adherence in their daily practice, the authors analyse the real effectiveness of sev |
出版日期 | Book 2018 |
关键词 | drug adherence monitoring; resistant hypertension; clinical trials; healthcare network; cost-effectivene |
版次 | 1 |
doi | https://doi.org/10.1007/978-3-319-76593-8 |
isbn_softcover | 978-3-030-09528-4 |
isbn_ebook | 978-3-319-76593-8Series ISSN 2366-4606 Series E-ISSN 2366-4614 |
issn_series | 2366-4606 |
copyright | Springer International Publishing AG, part of Springer Nature 2018 |